{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02613",
      "entity_text" : "adalimumab drug antibodies",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Of the three patients who had previously failed multiple biologics, all had failed three anti-TNFs (infliximab, adalimumab, etanercept); indeed in one patient we demonstrated low adalimumab drug levels and development of adalimumab drug antibodies prior to switching to certolizumab.",
  "reading_complete" : "2020-08-04T14:26:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:21:47Z",
  "trigger" : "levels",
  "evidence" : [ "levels and development of adalimumab drug antibodies" ],
  "pmc_id" : "6522617",
  "score" : 0
}